SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-003621
Filing Date
2018-03-20
Accepted
2018-03-20 09:00:42
Documents
10
Period of Report
2018-03-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33915
2 ex19-1.htm EX-19.1 23996
3 ex19-2.htm EX-19.2 14952
4 ex20-1.htm EX-20.1 3232
5 ex19-1_001.jpg GRAPHIC 3615
6 ex19-1_002.jpg GRAPHIC 122978
7 ex19-1_003.jpg GRAPHIC 19159
8 ex20-1_001.jpg GRAPHIC 291181
9 ex20-1_002.jpg GRAPHIC 1467407
10 ex20-1_003.jpg GRAPHIC 99973
  Complete submission text file 0001493152-18-003621.txt   2837165
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53832 | Film No.: 18700737
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9